Perspectives of drug manufacturers : abbreviated new drug applications.
(eBook)
Description
Also in this Series
More Details
Notes
Citations
United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections. (1990). Perspectives of drug manufacturers: abbreviated new drug applications . Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections. 1990. Perspectives of Drug Manufacturers: Abbreviated New Drug Applications. Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections. Perspectives of Drug Manufacturers: Abbreviated New Drug Applications Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections, 1990.
MLA Citation, 9th Edition (style guide)United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections. Perspectives of Drug Manufacturers: Abbreviated New Drug Applications Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections, 1990.
Staff View
Grouping Information
| Grouped Work ID | ca301492-972a-dd0b-3e20-969c742b5db0-eng |
|---|---|
| Full title | perspectives of drug manufacturers abbreviated new drug applications |
| Author | united states department of health and human servi |
| Grouping Category | book |
| Last Update | 2023-05-05 15:45:20PM |
| Last Indexed | 2024-07-03 00:55:47AM |
Book Cover Information
| Image Source | default |
|---|---|
| First Loaded | Sep 18, 2022 |
| Last Used | May 18, 2024 |
Marc Record
| First Detected | Jul 15, 2016 12:00:00 AM |
|---|---|
| Last File Modification Time | May 05, 2023 03:51:57 PM |
MARC Record
| LEADER | 01710cam a2200421 i 4500 | ||
|---|---|---|---|
| 001 | ocn953619871 | ||
| 003 | OCoLC | ||
| 005 | 20160715104931.0 | ||
| 006 | m o d f | ||
| 007 | cr m|||||||||| | ||
| 008 | 160715s1990 dcua ob f000 0 eng c | ||
| 040 | |a GPO|b eng|e rda|e pn|c GPO|d MvI | ||
| 042 | |a pcc | ||
| 043 | |a n-us--- | ||
| 074 | |a 0445-B-07 (online) | ||
| 086 | 0 | |a HE 1.75:OEI-12-90-00770 | |
| 088 | |a OEI-12-90-00770 | ||
| 099 | |a HE 1.75:OEI-12-90-00770 | ||
| 110 | 1 | |a United States.|b Department of Health and Human Services.|b Office of Inspector General.|b Office of Evaluation and Inspections,|e author. | |
| 245 | 1 | 0 | |a Perspectives of drug manufacturers :|b abbreviated new drug applications. |
| 246 | 3 | 0 | |a Abbreviated new drug applications |
| 264 | 1 | |a [Washington, D.C.] :|b Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections,|c 1990. | |
| 300 | |a 1 online resource ([27] pages) :|b illustrations | ||
| 336 | |a text|2 rdacontent | ||
| 337 | |a computer|2 rdamedia | ||
| 338 | |a online resource|2 rdacarrier | ||
| 500 | |a Title from title screen (viewed July 14, 2016). | ||
| 500 | |a "February 1990." | ||
| 500 | |a "OEI-12-90-00770." | ||
| 500 | |a GPO Cataloging Record Distribution Program (CRDP). | ||
| 504 | |a Includes bibliographical references (page 15). | ||
| 610 | 1 | 0 | |a United States.|b Food and Drug Administration|x Effectiveness|x Evaluation. |
| 650 | 0 | |a Generic drugs|z United States. | |
| 650 | 0 | |a Pharmaceutical policy|z United States. | |
| 650 | 0 | |a Drug approval|z United States. | |
| 650 | 0 | |a Pharmaceutical industry|z United States. | |
| 856 | 4 | 0 | |u https://purl.fdlp.gov/GPO/gpo69754 |
| 949 | |a HE 1.75:OEI-12-90-00770|t x | ||
